Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today ...
Statera Managing Agency Limited, a subsidiary of Octave Ventures, has received regulatory approval to act as a Lloyd’s ...
Octave Ventures, rebranded Beat Capital Partners, has received approval from Lloyd's to launch Statera Managing Agency and ...
US commercial stage precision-care company Octave Bioscience has announced the appointment of Kirk Stockwood as senior vice ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
MENLO PARK, Calif., January 08, 2026--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback